Cephagenix ApS: Financial statements 2023
CVR: 41175486
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Cephagenix ApS (CVR 41175486) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,681,231 and a net result of DKK -2,474,554 compared with DKK -2,197,967 the year before. Equity in the 2023 report amounted to DKK 787,787. The solvency ratio was 96.3%.
- Gross Profit
- DKK -2,681,231
- Profit/Loss
- DKK -2,474,554
- Equity
- DKK 787,787
- Total Assets
- DKK 818,126
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -2.7M | -2.5M | 788K | 0 |
| 2022 | - | -3.1M | -2.2M | 2.7M | 0 |
| 2021 | - | -1.9M | -1.4M | 1.6M | - |
| 2020 | - | -1.3M | -941K | 259K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Cephagenix ApS has published its annual report for 2022. Gross profit came to DKK -3,063,396, and the net result was DKK -2,197,967.
About Cephagenix ApS
Cephagenix ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ismahane Bali. The company is owned by Cephagenix SAS. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -176,320 and a net result of DKK -105,608 compared with DKK -2,474,554 the year before. Equity in the 2024 report amounted to DKK 82,179.